Harvey E. Behrend

Array ( [id] => 3550570 [patent_doc_number] => 05571806 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-11-05 [patent_title] => 'Dibenz[b,f][1,4]oxazepin(and thiazepin)-11(10H)-ones and-thiones and their use in the prevention or treatment of HIV infection' [patent_app_type] => 1 [patent_app_number] => 8/271350 [patent_app_country] => US [patent_app_date] => 1994-07-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7285 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 431 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/571/05571806.pdf [firstpage_image] =>[orig_patent_app_number] => 271350 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3649068 [patent_doc_number] => 05639767 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-06-17 [patent_title] => 'Therapeutical method for treating dermatoses based on the use of O-esters of L-carnitine with aromatic acids' [patent_app_type] => 1 [patent_app_number] => 8/253051 [patent_app_country] => US [patent_app_date] => 1994-06-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 947 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 71 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/639/05639767.pdf [firstpage_image] =>[orig_patent_app_number] => 253051 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3539372 [patent_doc_number] => 05494932 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-02-27 [patent_title] => 'Sulfonic stilbene derivatives in the treatment of viral disease' [patent_app_type] => 1 [patent_app_number] => 8/248851 [patent_app_country] => US [patent_app_date] => 1994-05-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 9 [patent_no_of_words] => 6600 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 92 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/494/05494932.pdf [firstpage_image] =>[orig_patent_app_number] => 248851 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3113305 [patent_doc_number] => 05464850 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1995-11-07 [patent_title] => 'Synergistic preservative systems for chemistry reagents' [patent_app_type] => 1 [patent_app_number] => 8/245303 [patent_app_country] => US [patent_app_date] => 1994-05-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3410 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 74 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/464/05464850.pdf [firstpage_image] =>[orig_patent_app_number] => 245303 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3545354 [patent_doc_number] => 05554655 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-09-10 [patent_title] => 'Method of treating HIV infection' [patent_app_type] => 1 [patent_app_number] => 8/229142 [patent_app_country] => US [patent_app_date] => 1994-04-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2694 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/554/05554655.pdf [firstpage_image] =>[orig_patent_app_number] => 229142 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1589276 [patent_doc_number] => 06482810 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-11-19 [patent_title] => 'Antibiotic composition for inhibition of angiogenesis' [patent_app_type] => B1 [patent_app_number] => 08/227100 [patent_app_country] => US [patent_app_date] => 1994-04-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 2 [patent_no_of_words] => 3913 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 83 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/482/06482810.pdf [firstpage_image] =>[orig_patent_app_number] => 08227100 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4397385 [patent_doc_number] => 06297278 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-10-02 [patent_title] => 'Method for inactivating sexually transmitted enveloped viruses' [patent_app_type] => 1 [patent_app_number] => 8/223096 [patent_app_country] => US [patent_app_date] => 1994-04-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 5114 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 220 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/297/06297278.pdf [firstpage_image] =>[orig_patent_app_number] => 223096 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1246039 [patent_doc_number] => 06677362 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-01-13 [patent_title] => 'Solid pharmaceutical dispersions' [patent_app_type] => B1 [patent_app_number] => 08/218495 [patent_app_country] => US [patent_app_date] => 1994-03-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2518 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 142 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/677/06677362.pdf [firstpage_image] =>[orig_patent_app_number] => 08218495 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3659088 [patent_doc_number] => 05627186 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-05-06 [patent_title] => 'Antiviral combinations' [patent_app_type] => 1 [patent_app_number] => 8/219176 [patent_app_country] => US [patent_app_date] => 1994-03-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 7 [patent_no_of_words] => 5492 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 105 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/627/05627186.pdf [firstpage_image] =>[orig_patent_app_number] => 219176 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3550809 [patent_doc_number] => 05547964 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-08-20 [patent_title] => 'Medical use for tachykinin antagonists' [patent_app_type] => 1 [patent_app_number] => 8/214306 [patent_app_country] => US [patent_app_date] => 1994-03-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12125 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 3796 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/547/05547964.pdf [firstpage_image] =>[orig_patent_app_number] => 214306 [rel_patent_id] =>[rel_patent_doc_number] =>)